A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.
Taking a GLP-1 drug? Here’s what the safety evidence really shows
- Post author:admin
- Post published:
- Post category:uncategorized
- Post comments:0 Comments